filmov
tv
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metas...
Показать описание
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
0:54:18
1:02:35
1:02:35
0:54:18
1:02:35
0:54:56
0:01:15
0:50:09
0:54:16
0:18:14
0:21:28
0:03:36
0:31:39
0:02:03
0:02:41
0:54:03
0:57:16
0:08:14
0:01:02
0:01:38
0:04:18
0:07:02
0:01:06
1:00:29